Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/112717
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer
Author: Fuhrman-Luck, R.
Silva, M.
Dong, Y.
Irving-Rodgers, H.
Stoll, T.
Hastie, M.
Loessner, D.
Gorman, J.
Clements, J.
Citation: Proteomics - Clinical Applications, 2014; 8(5-6):403-415
Publisher: Wiley - VCH Verlag GmbH & CO. KGaA
Issue Date: 2014
ISSN: 1862-8346
1862-8354
Statement of
Responsibility: 
Ruth Anna Fuhrman-Luck, Munasinghage Lakmali Silva, Ying Dong, Helen Irving-Rodgers, Thomas Stoll, Marcus Lachlan Hastie, Daniela Loessner, Jeffrey John Gorman and Judith Ann Clements
Abstract: Rapidly developing proteomic tools are improving detection of deregulated kallikrein-related peptidase (KLK) expression, at the protein level, in prostate and ovarian cancer, as well as facilitating the determination of functional consequences downstream. MS-driven proteomics uniquely allows for the detection, identification, and quantification of thousands of proteins in a complex protein pool, and this has served to identify certain KLKs as biomarkers for these diseases. In this review, we describe applications of this technology in KLK biomarker discovery and elucidate MS-based techniques that have been used for unbiased, global screening of KLK substrates within complex protein pools. Although MS-based KLK degradomic studies are limited to date, they helped to discover an array of novel KLK substrates. Substrates identified by MS-based degradomics are reported with improved confidence over those determined by incubating a purified or recombinant substrate and protease of interest, in vitro. We propose that these novel proteomic approaches represent the way forward for KLK research, in order to correlate proteolysis of biological substrates with tissue-related consequences, toward clinical targeting of KLK expression and function for cancer diagnosis, prognosis, and therapies.
Keywords: Cancer; degradomics; kallikrein; protease
Rights: © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
RMID: 0030090069
DOI: 10.1002/prca.201300098
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.